Toremifene in Treating Patients With Ovarian Cancer

Summary

RATIONALE: Estrogen can stimulate the growth of ovarian cancer cells. Hormone therapy using toremifene may fight ovarian cancer by reducing the production of estrogen. PURPOSE: Randomized phase II trial to study the effectiveness of toremifene in treating patients who have recurrent or refractory ovarian cancer.

Timeline

Start

1999-07-22

Primary completion

2017-02-22

Completion

2017-02-22

Drugs

Indications